{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:53:58Z","timestamp":1779890038519,"version":"3.53.1"},"reference-count":55,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.2217\/imt-2017-0108","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T05:55:08Z","timestamp":1508910908000},"page":"1175-1183","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["Immune-Related Musculoskeletal Toxicities Among Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review"],"prefix":"10.1080","volume":"9","author":[{"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[{"name":"Clinical Oncology Department,","place":["Cairo,, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Eltobgy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine,","place":["Cairo,, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Oweira","sequence":"additional","affiliation":[{"name":"Oncology Department,","place":["Cham,, Switzerland"]},{"name":"OncoCentrum Zurich,","place":["Cham,, Switzerland"]},{"name":"Surgical Center Zurich \u2013 Hirslanden Hospital Zurich,","place":["Zurich,, Switzerland"]},{"name":"Surgery Department,","place":["Jena,, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Giryes","sequence":"additional","affiliation":[{"name":"Oncology Department,","place":["Cham,, Switzerland"]},{"name":"OncoCentrum Zurich,","place":["Cham,, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Tekbas","sequence":"additional","affiliation":[{"name":"Surgery Department,","place":["Jena,, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Decker","sequence":"additional","affiliation":[{"name":"Oncology Department,","place":["Zurich,, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1100"},{"key":"e_1_3_2_4_1","first-page":"357","article-title":"Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway","volume":"7","author":"Momtaz P","year":"2014","unstructured":"Momtaz P , PostowMA. Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway. Curr. Pharmacogenomics Person. Med.7, 357\u2013365 (2014).","journal-title":"Curr. Pharmacogenomics Person. Med."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.4032"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70189-5"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611299"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0243-5"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70090-6"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu205"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.1041"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1193-1"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.13943"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00083-2"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2873-x"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds213"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70324-8"},{"issue":"4","key":"e_1_3_2_20_1","first-page":"712","article-title":"Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma","volume":"21","author":"Gibney GT","year":"2015","unstructured":"Gibney GT , KudchadkarRR, DecontiRCet al. Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma. Ann. Oncol.21(4), 712\u2013720 (2015).","journal-title":"Ann. Oncol."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70381-4"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70189-5"},{"issue":"8","key":"e_1_3_2_23_1","first-page":"828","article-title":"Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal RE","year":"2010","unstructured":"Royal RE , LevyC, TurnerKet al. Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. Int. J. Immunother. Cancer Res.33(8), 828\u2013833 (2010).","journal-title":"Int. J. Immunother. Cancer Res."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.118"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1085969"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.222"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.87"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465816636557"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2016.11.007"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2015-0020"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2016.06.008"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2017.1296765"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","unstructured":"Eltobgy M OweiraH PetrauschUet al. Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. 17(7) 725\u2013736 (2017).","DOI":"10.1080\/14737175.2017.1336088"},{"key":"e_1_3_2_34_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].","author":"Higgins JPT","year":"2011","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Higgins JPT , GreenS (Eds). The Cochrane Collaboration, (2011). www.cochrane-handbook.org"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2463"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.022"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30007-4"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60958-2"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw655"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw126"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.02.024"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1265115"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.03.003"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0170"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12991"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2770"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.2233"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.001"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.6750"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx225"},{"issue":"2","key":"e_1_3_2_55_1","first-page":"353","article-title":"The autoimmune disease complex interstitial pneumonia\/dermatomyositis in the light of endocrinology and cancer epidemiology","volume":"23","author":"Kodama M","year":"2009","unstructured":"Kodama M , KodamaM. The autoimmune disease complex interstitial pneumonia\/dermatomyositis in the light of endocrinology and cancer epidemiology. In vivo23(2), 353\u2013356 (2009).","journal-title":"In vivo"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00206"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574887111666160330120712"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2017-0108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:33:25Z","timestamp":1770896005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2017-0108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":55,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.2217\/imt-2017-0108"],"URL":"https:\/\/doi.org\/10.2217\/imt-2017-0108","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}